The precise role of vasopressin in the pathophysiology of cardiovascular di
sease is controversial, but this peptide hormone is important for several r
easons. Firstly, circulating concentrations of vasopressin are elevated in
heart failure and some forms of hypertension. Secondly, there is evidence t
hat vasopressin is synthesized not only in the hypophysial-pituitary axis b
ut also in peripheral tissues including the heart where it acts as a paracr
ine hormone. Thirdly, vasopressin has vasoconstrictor, mitogenic, hyperplas
tic and renal fluid retaining properties which, by analogy with angiotensin
II, may have deleterious effects when present in chronic excess. Finally,
the availability of orally active non-peptide vasopressin receptor antagoni
sts allows vasopressin receptor antagonism to be considered as a therapeuti
c option in cardiovascular disease.